S. 927 · 119th Congress · Health
Protecting Pharmacies in Medicaid Act
A bill that started in the Senate. To become law it must pass the Senate and the House in identical form and be signed by the President.
Where it stands
In committee in the Senate
- Introduced — doneMar 11, 2025
- Committee — not yet
- Passed the Senate — not yet
- Passed the House — not yet
- Sent to the President — not yet
- Became law — not yet
Latest action · Mar 11, 2025
Read twice and referred to the Committee on Finance.
What this bill means
In plain English
This bill provides funds beginning in FY2026 for the Centers for Medicare & Medicaid Services to survey retail and non-retail pharmacies (e.g., mail-order pharmacies) to determine average prices of covered outpatient drugs under Medicaid. Pharmacies that fail to participate in the surveys are subject to civil penalties.
From the official summary by the Congressional Research Service (introduced in senate version). The full summary is below.
If it passes
It becomes federal law, and what it describes takes effect on the dates written into the bill.
What still has to happen
- 1A Senate committee must take it up and approve it. Most bills never get past this step.
- 2Then the full Senate must pass it.
- 3Then the House must pass it in the same form.
- 4Then it goes to the President to sign or veto.
If it doesn't pass
- Nothing changes. The law stays exactly as it is today — a bill has no effect unless it is enacted.
- This bill expires when the 119th Congress ends on Jan 3, 2027. To try again, a member would have to introduce it as a new bill in the next Congress and start over.
Read the full official summaryCongressional Research Service · Introduced in Senate · Mar 11, 2025
This bill provides funds beginning in FY2026 for the Centers for Medicare & Medicaid Services to survey retail and non-retail pharmacies (e.g., mail-order pharmacies) to determine average prices of covered outpatient drugs under Medicaid. Pharmacies that fail to participate in the surveys are subject to civil penalties.
The bill additionally provides funds for FY2026 for the Office of the Inspector General of the Department of Health and Human Services to study the results of the survey and report accordingly to Congress.
The bill also requires pass-through pricing models, and prohibits spread-pricing, for payment arrangements with pharmacy benefit managers under Medicaid.
Who started it
Sponsor — the member who introduced it

Introduced in the Senate on Mar 11, 2025.
See Peter Welch's votes and donorsCosponsors — members who signed on in support
3cosponsors
1 Democrat · 2 Republicans
Members of both parties have signed on.
- Roger MarshallR-KS
- Mark R. WarnerD-VA
- Bill CassidyR-LA
Committees handling it
A bill is sent to the committee that covers its subject. The committee decides whether it ever reaches a vote of the full chamber.
Finance Committee
Senate
- Referred To · Mar 11, 2025
Full timeline
Every recorded action on S. 927, from the day it was introduced to the most recent, exactly as the House, the Senate, and the Library of Congress logged it.
- IntroducedSenate
Introduced in Senate
Read twice and referred to the Committee on Finance.
Have a view on S. 927? Your leaders vote on it.
Tell your senators and your representative where you stand. We fill in who represents you and reference this bill in the letter.
Write your leaders about thisSource: Congress.gov record for S. 927(opens in new tab)